serine Hydroxymethyltransferase 2 (Mitochondrial) (SHMT2) Peptide
-
- Target See all SHMT2 products
- SHMT2 (serine Hydroxymethyltransferase 2 (Mitochondrial) (SHMT2))
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-SHMT2 antibody (Catalog #: ARP46129_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- SHMT2 (serine Hydroxymethyltransferase 2 (Mitochondrial) (SHMT2))
- Background
-
SHMT2 plays a role in interconversion of serine and glycine.
Alias Symbols: GLYA, SHMT
Protein Interaction Partner: CSNK2B,NDRG1,SHMT2,BRCC3,BRE,C19orf62,EIF1B,GNAS
Protein Size: 504 - Molecular Weight
- 56 kDa
- Gene ID
- 6472
- NCBI Accession
- NM_005412, NP_005403
- UniProt
- P34897
-